Evidence map›Paper›PMID 28192603›Full record

ArticleFEBS letters2017

Characterizing isomiR variants within the microRNA-34/449 family.

Olivier Mercey, Alexandra Popa, Amélie Cavard, Agnès Paquet, Benoît Chevalier, Nicolas Pons, Virginie Magnone, Joséphine Zangari, Patrick Brest, Laure-Emmanuelle Zaragosi and 4 more

Abstract readLetter
In one paragraph

Article in FEBS letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Olivier MerceyCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Alexandra PopaCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Amélie CavardCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Agnès PaquetCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Benoît ChevalierCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Nicolas PonsCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Virginie MagnoneCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Joséphine ZangariCNRS, INSERM, IRCAN, FHU-OncoAge, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Patrick BrestCNRS, INSERM, IRCAN, FHU-OncoAge, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Laure-Emmanuelle ZaragosiCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Gilles PonzioCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Kevin LebrigandCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Pascal BarbryCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.
Brice MarcetCNRS, IPMC, Université Côte d'Azur, Sophia-Antipolis, Valbonne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miR-34/449 microRNAs are conserved regulators of multiciliated cell differentiation. Here, we evidence and characterize expression of two isomiR variant sequences from the miR-34/449 family in human airway epithelial cells. These isomiRs differ from their canonical counterparts miR-34b and miR-449c by one supplemental uridine at their 5'-end, leading to a one-base shift in their seed region. Overexpression of canonical miR-34/449 or 5'-isomiR-34/449 induces distinct gene expression profiles and biological effects. However, some target transcripts and functional activities are shared by both canonical microRNAs and isomiRs. Indeed, both repress important targets that result in cell cycle blockage and Notch pathway inhibition. Our findings suggest that 5'-isomiR-34/449 may represent additional mechanisms by which miR-34/449 family finely controls several pathways to drive multiciliogenesis.

Indexed as

Gene Expression RegulationA549 CellsBase SequenceCell CycleEpithelial CellsGene Expression ProfilingHEK293 CellsHumansMicroRNAsNasal MucosaPrimary Cell Cultureras ProteinsReceptor, Notch1rho Guanine Nucleotide Dissociation Inhibitor betaSignal TransductionARHGDIB protein, humanMicroRNAsMIRN34 microRNA, humanMIRN449 microRNA, humanNOTCH1 protein, humanras ProteinsReceptor, Notch1rho Guanine Nucleotide Dissociation Inhibitor betaRRAS protein, humanisomiRmicroRNAmiR-34miR-449miRBasemulticiliated cell

Identifiers

PMID28192603
PMCPMC5363356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.